Gilad Kaplan

Title: Gilad Kaplan: Innovator in Antibody Research

Introduction

Gilad Kaplan is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of antibody research, holding a total of 4 patents. His work focuses on developing binding proteins that have the potential to treat and prevent infections.

Latest Patents

Kaplan's latest patents include innovative approaches to combat infections caused by Klebsiella pneumoniae. One of his notable patents is for Anti-O2 antibodies, which provide binding proteins that specifically target O2. These proteins induce opsonophagocytic killing of Klebsiella pneumoniae and offer protection against lethal challenges in mice. Another significant patent is for Anti-O1 antibodies, which also provide binding proteins that specifically bind to O1, facilitating the reduction or treatment of infections in subjects.

Career Highlights

Throughout his career, Kaplan has worked with reputable companies such as MedImmune Limited and Humabs Biomed SA. His experience in these organizations has allowed him to advance his research and contribute to the development of novel therapeutic solutions.

Collaborations

Kaplan has collaborated with notable professionals in his field, including Qun Wang and Charles K. Stover. These collaborations have further enriched his research and innovation efforts.

Conclusion

Gilad Kaplan's work in antibody research exemplifies his commitment to advancing medical science. His patents and collaborations highlight his significant contributions to the field, making him a noteworthy inventor in the realm of innovations.